SY5-22151-61834
2 vaccinations
6 coded responses
22 check-ins
6 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 631 / MO
- Registered
- 2021-02-04
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-04
Registered in v-safe
-
2021-02-04
Dose 1 — Moderna
- 2021-02-04
-
2021-02-05
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: Good · Site: PainFree text: Very mild lightheadednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-06
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness, Postpartum state — Feeling: Good · Site: PainFree text: Mild lightheadedness, but may be due to being 10 days postpartum.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-07
- 2021-02-08
- 2021-02-10
- 2021-02-11
-
2021-02-18
Survey response — day 14, dose 1MedDRA: Breast abscess — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Breast abscess - presumably not vaccine relatedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-27
-
2021-03-05
Dose 2 — Moderna
-
2021-03-05
Survey response — day 0, dose 2MedDRA: Fatigue — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Fatigue may be due to being postpartumMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-08
- 2021-03-11
- 2021-03-12
- 2021-03-21
- 2021-03-28
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-06-04
- 2021-08-06
-
2021-09-05
Survey response — 6 months, dose 2MedDRA: Cough, Pyrexia, Respiratory tract congestion, Sneezing, Unevaluable event — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Cough, sneezing, congestion, feverish · Healthcare visit (other): Drive through testing through major retail pharmacyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-05
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-09-09
-
2022-03-05
Survey response — 12 months, dose 2MedDRA: Chills, Laryngitis, Pain — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Laryngitis, chills, body achesMedDRA releases: 2024-11 · check-in free text available
-
2022-03-05
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-04 | Moderna | |
| 2 | 2021-03-05 | Moderna |
Call center
3 call center cases
3 unsuccessful
1 wait over 3 months for a first call
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): Very mild lightheadedness
Systemic reaction (other): Mild lightheadedness, but may be due to being 10 days postpartum.
Release 4 — day 14, dose 1
Symptoms: Breast abscess - presumably not vaccine related
Release 5 — day 0, dose 2
Systemic reaction (other): Fatigue may be due to being postpartum
Release 9 — 6 months, dose 2
Symptoms: Cough, sneezing, congestion, feverish
Healthcare visit (other): Drive through testing through major retail pharmacy
Release 11 — 12 months, dose 2
Symptoms: Laryngitis, chills, body aches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | · | ✓ |
| SD | Breast abscess | ✓ | ✓ | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | Laryngitis | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | ✓ | · | ✓ |
| SD | Respiratory tract congestion | ✓ | · | ✓ |
| SD | Sneezing | ✓ | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Postpartum state | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release